U.S. markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.60+0.38 (+7.28%)
At close: 04:00PM EDT
5.59 -0.01 (-0.18%)
After hours: 05:12PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close5.22
Bid5.51 x 3000
Ask5.60 x 4000
Day's Range5.16 - 5.77
52 Week Range4.51 - 36.36
Avg. Volume6,280,637
Market Cap1.257B
Beta (5Y Monthly)1.26
PE Ratio (TTM)N/A
EPS (TTM)-0.89
Earnings DateAug 01, 2022 - Aug 05, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for PACB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pacific Biosciences of Californ
    Daily – Vickers Top Buyers & Sellers for 01/14/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    4 months agoArgus Research
View more
  • GlobeNewswire

    PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows

    Advanced Automation Aims to Optimize Service Lab Efficiency and Highly Reproducible Data Production from HiFi Long-Read SequencingMENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with genome analysis company iLAC, Inc. (iLAC) and Robotic Biology Institute, Inc. (RBI) to develop fully automated end-to-end workflows for PacBio’s Sequel II and Sequel IIe HiFi

  • GlobeNewswire

    PacBio to Participate in the BofA Securities 2022 Healthcare Conference

    MENLO PARK, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that it will be participating in the upcoming BofA Securities 2022 Healthcare Conference in Las Vegas, Nevada. PacBio’s management is scheduled to present on Thursday, May 12 at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time. The live webcast can be accessed at the company’s investors page at A replay of the webcast will be available for at least 30 days following the presentation. Abou

  • Zacks

    PacBio's (PACB) Q1 Earnings Miss Estimates, Revenues Beat

    PacBio (PACB) sees strength in Q1 segmental revenues, led by robust consumable and instrument sales.